Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × Tablets × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

TP53 Y220C Mutation 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Localized Prostate Cancer 1 Head and Neck Neoplasms 1 Deglutition Disorders 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Bevacizumab 43 Cetuximab 37 Fluorouracil 34 pembrolizumab 33 Leucovorin 30 Oxaliplatin 29 Specimen Handling 26 Irinotecan 22 Biopsy 17 regorafenib 15 Magnetic Resonance Spectroscopy 14 Nivolumab 13 IFL protocol 13 Folfox protocol 13 Standard of Care 12 Panitumumab 11 Carboplatin 11 Capecitabine 11 HMPL-013 10 trifluridine tipiracil drug combination 9 Trifluridine 9 Gemcitabine 9 Cisplatin 9 tislelizumab 8 atezolizumab 7 Pemetrexed 7 Paclitaxel 7 Methods 7 Educational Status 7 Early Intervention, Educational 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07435584 2026-02-27

EVER-RECODE

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡